Skip to main content
. 2011 Oct;55(10):4692–4697. doi: 10.1128/AAC.01248-10

Fig. 2.

Fig. 2.

Time-kill curves of MUT056399 activity against MSSA ATCC 29213. The experiments were performed by counting viable bacteria at 4, 6, 8, and 24 h. Mean values represent data from at least two experiments. (A) Filled lozenges, control; open squares, vancomycin at 4 × MIC (4 μg/ml); filled triangles, linezolid at 4 × MIC (16 μg/ml); filled circles, MUT056399 at 4 × MIC (0.25 μg/ml); crosses, MUT056399 at 16 × MIC (1 μg/ml); open circles, MUT056399 at 64 × MIC (4 μg/ml). (B) Values for bacterial cultures that contained 50% (vol/vol) human serum. Filled lozenges, control; open squares, vancomycin at 4 × MIC (4 μg/ml); filled triangles, linezolid at 4 × MIC (16 μg/ml). Under these conditions, the cultures were exposed to MUT056399 at 4 × MIC (4 μg/ml) (filled circles).